2026: 3rd Peptide-Based Therapeutics Summit

By Hannah Bachmeier -- Check out our latest paper discussing how the 12 Principles of Green Chemistry are being applied to ncAA manufacturing to eliminate hazardous solvents and drastically optimize Process Mass Intensity (PMI).

Catch Peter Hutchings in Boston, MA for TIDES USA 2026!

Our Founder and CEO, Tina Boville, will be one of the featured speakers at the Peptide Drug Hunting Consortium's Synthesis Innovation Webinar!

Meet with Peter Hutchings in NYC for DCAT Week.

Nat Goldberg and Jimmy Mann will be in attendance - be sure to attend Nat's talk on Day 2!

Scalable continuous evolution for the generation of diverse enzyme variants encompassing promiscuous activities

We show that ketone-derived enolates can serve as nucleophiles in the TrpB reaction to achieve the asymmetric alkylation of ketones

Our founders were interviewed in this strategic news publication for the chemical and pharmaceutical industries.

Our founder & team are featured in Made in San Leandro: Celebrating Women in Manufacturing series

Our founder presents "Expanding the Universe of Noncanonical Amino Acids with Biocatalysis"

Our founder discusses "Novel Amino Acids for Peptide Therapeutics via Green Biocatalysis"

Come meet our founder & team as we discuss the critical role that ncAAs play in peptide drug development

Check out our latest paper discussing how noncanonical amino acids are used in discovery, manufacturing, as well as the challenges in the industry

Aralez Bio announces Series A Financing Round

This review examines the long and storied career of TrpS from the perspective of its application in ncAA synthesis and biocatalytic cascades.